Background: High-Intensity Focused Ultrasound (HIFU) is widely used for non-invasive facial and neck rejuvenation, promoting collagen remodeling through controlled thermal and mechanical effects. While its clinical outcomes are well established, the immediate biochemical response—particularly oxidative stress—has not been directly quantified in humans. Objective: This pilot study aimed to evaluate acute changes in oxidative stress levels following a single HIFU session in healthy adult volunteers. Methods: Nineteen healthy volunteers were enrolled; fourteen received HIFU treatment and five served as contemporaneous controls. Venous blood samples were collected at baseline and immediately after treatment (or 40 min later for controls). Oxidative stress levels were quantified using an enzyme-linked immunosorbent assay (ELISA). Pre–post differences were assessed using paired t-tests, and between-group comparisons were performed using Δ-scores and mixed-effects modeling. Results: Oxidative index values remained unchanged in controls (18.55 ± 0.57 μmol/L pre vs. 18.55 ± 0.57 μmol/L post; Δ = 0.00 ± 0.00; p = 1.00). In contrast, HIFU treatment induced a significant acute increase (19.99 ± 1.54 μmol/L pre vs. 22.39 ± 2.29 μmol/L post; Δ = 2.63 ± 2.22 μmol/L; p = 0.0007). Between-group Δ differences were significant, and mixed-effects modeling revealed a significant time × group interaction, indicating an HIFU-specific oxidative response. No adverse effects were observed, and all treated participants demonstrated immediate aesthetic improvement. Conclusions: A single HIFU session elicits an acute increase in oxidative stress, likely reflecting controlled thermal stimulation and early tissue remodeling. Longitudinal studies are warranted to assess the persistence of these biochemical changes and their contribution to long-term clinical outcomes.
High-intensity focused ultrasound (HIFU) is widely used for non-invasive facial and neck rejuvenation; however, its longer-term systemic biochemical effects remain insufficiently characterized. This prospective controlled pilot study investigated longitudinal changes in systemic oxidative status at baseline and 3 and 6 months following a single HIFU treatment. Thirty healthy adults were enrolled, including 25 participants who underwent facial and neck HIFU and 5 untreated participants serving as a comparison group. Serum total oxidant status (TOS) was quantified using an enzyme-linked immunosorbent assay (ELISA)-based method, and longitudinal changes were assessed using mixed-effects modeling. Baseline TOS did not differ significantly between groups (19.54 ± 1.49 vs. 19.78 ± 1.81 μmol/L; p = 0.794). A significant group × time interaction was observed (Wald χ2(2) = 21.78, p < 0.001). Within the HIFU group, TOS decreased at 3 months (17.31 ± 1.51 μmol/L; Bonferroni-adjusted p < 0.001) and remained below baseline at 6 months (18.34 ± 0.95 μmol/L; p < 0.001), despite a partial increase between 3 and 6 months (p = 0.002). Three participants (12.0%) reported mild, transient deep-tissue tenderness; no serious adverse events occurred. Overall, HIFU was associated with a distinct longitudinal TOS pattern, supporting further investigation of redox and tissue-remodeling biomarkers.